Intraorbital injection of rituximab: a new approach for active thyroid-associated orbitopathy, a prospective case series. | Minerva Endocrinol;38(2): 173-9, 2013 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Intraorbital injection of rituximab: a new approach for active thyroid-associated orbitopathy, a prospective case series.

Savino, G; Balia, L; Colucci, D; Battendieri, R; Gari, M; Corsello, S M; Pontecorvi, A; Dickmann, A.

Affiliation

Savino G; Institute of Ophthalmology, Catholic University of the Sacred Heart, Rome, Italy. g.sav@rm.unicatt.it

Minerva Endocrinol ; 38(2): 173-9, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23732371

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Diseases / Graves Ophthalmopathy / Eye Diseases / Antibodies, Monoclonal, Murine-Derived Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Minerva Endocrinol Year: 2013 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Diseases / Graves Ophthalmopathy / Eye Diseases / Antibodies, Monoclonal, Murine-Derived Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Minerva Endocrinol Year: 2013 Document type: Article Affiliation country: